Geneial, Inc.
PrivateLast Round
Grant
Nov 1, 2023
Total Funding Raised
$2.3M
Company Overview
Geneial, Inc. is a healthcare technology company that provides a precision medicine data infrastructure and patient engagement platform for rare and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Precision Medicine, Patient Engagement, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneial, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Geneial, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2023 | ||||
| Grant | Sep 22, 2022 | ||||
| Pre Seed | Jun 1, 2021 |
Geneial, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Library of Medicine | Grant |
| NIH RADx | Grant |
| Creative Destruction Lab | Accelerator |
Geneial, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Geneial, Inc.'s valuation, stock price, and market status.